No Data
Acurx Pharmaceuticals Earnings Call Highlights Funding Risk
Analysts Are Bullish on Top Healthcare Stocks: Candel Therapeutics (CADL), Acurx Pharmaceuticals (ACXP)
Acurx Pharmaceuticals Q2 EPS $(0.53) Misses $(0.37) Estimate
Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.37) by 43.24 percent. This is a 71.96 percent increase over
Express News | Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 Results and Provides Business Update
10-Q: Acurx Pharmaceuticals | 10-Q: Quarterly report
ACXP Advances Ibezapolstat Trial in High-Risk C. Difficile Patients